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Abstract
Background Compensatory-reserve-weighted intracranial pressure (wICP) has recently been suggested as a supplementary
measure of intracranial pressure (ICP) in adult traumatic brain injury (TBI), with a single-center study suggesting an association
with mortality at 6 months. No multi-center studies exist to validate this relationship. The goal was to compare wICP to ICP for
association with outcome in a multi-center TBI cohort.
Methods Using the Collaborative European Neuro Trauma Effectiveness Research in TBI (CENTER-TBI) high-resolution
intensive care unit (ICU) cohort, we derived ICP and wICP (calculated as wICP = (1 −RAP) × ICP; where RAP is the compen-
satory reserve index derived from the moving correlation between pulse amplitude of ICP and ICP). Various univariate logistic
regression models were created comparing ICP and wICP to dichotomized outcome at 6 to 12months, based on Glasgow
Outcome Score—Extended (GOSE) (alive/dead—GOSE ≥ 2/GOSE = 1; favorable/unfavorable—GOSE 5 to 8/GOSE 1 to 4,
respectively). Models were compared using area under the receiver operating curves (AUC) and p values.
Results wICP displayed higher AUC compared to ICP on univariate regression for alive/dead outcome compared to mean ICP
(AUC 0.712, 95% CI 0.615–0.810, p = 0.0002, and AUC 0.642, 95% CI 0.538–746, p < 0.0001, respectively; no significant
difference on Delong’s test), and for favorable/unfavorable outcome (AUC 0.627, 95% CI 0.548–0.705, p = 0.015, and AUC
0.495, 95% CI 0.413–0.577, p = 0.059; significantly different using Delong’s test p = 0.002), with lower wICP values associated
with improved outcomes (p < 0.05 for both). These relationships on univariate analysis held true even when comparing the wICP
models with those containing both ICP and RAP integrated area under the curve over time (p < 0.05 for all via Delong’s test).
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Conclusions Compensatory-reserve-weighted ICP displays superior outcome association for both alive/dead and favorable/
unfavorable dichotomized outcomes in adult TBI, through univariate analysis. Lower wICP is associated with better global
outcomes. The results of this study provide multi-center validation of those seen in a previous single-center study.
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Introduction
Intracranial pressure (ICP) is well known to be associated with
outcome in adult traumatic brain injury (TBI), with higher
sustained levels of ICP linked to worse global outcome, and
particularly higher mortality [1, 3, 5, 9, 11]. Various studies to
date have documented such associations, with defined treat-
ment thresholds providing one of the main therapeutic targets
in the critical care management of the moderate/severe TBI
patient [3, 9].
Recent single-center retrospective work has suggested a
newer variant of ICP in adult TBI, termed compensatory-
reserve-weighted ICP [2, 6]. Using information from the con-
tinuously updating cerebral compensatory reserve index
(RAP) [2, 4, 12], derived from the moving correlation coeffi-
cient between pulse amplitude of ICP (AMP) and ICP, one can
derive a “weighted” ICP (wICP) as wICP = (1 −RAP) × ICP
[2, 6]. Such characteristics of wICP have been described in
detail within this previous work [2], with a strong association
between wICP and mortality being seen on descriptive
analysis.
However, despite the promise of wICP as a combined mea-
sure of ICP and compensatory reserve in adult TBI, these
conclusions have been based on data from a single-center
series [2, 6]. This limitation stems from the complexity of
the data required for analysis. With the completion of the
Collaborative European Neuro Trauma Effectiveness
Research in TBI (CENTER-TBI) study [8], the high-
resolution intensive care unit (ICU) cohort has provided a
multi-center data set with high-frequency digital physiologic
signals. The goal of this study is to compare the association
between ICP and wICP with global patient outcome in adult
TBI, using the CENTER-TBI high-resolution ICU cohort.
Methods
Patient population
All patients from the multi-center CENTER-TBI high-
resolution ICU cohort were included for this study. These
patients were prospectively recruited during the periods of
January 2015 to December 2017. A total of 21 centers in the
European Union (EU) recruited patients for this cohort. All
patients were admitted to ICU for their TBI during the course
of the study, with high-frequency digital signals recorded from
their ICU monitors during the course of their ICU stay. All
patients suffered predominantly from moderate to severe TBI
(moderate = Glasgow Coma Score (GCS) 9 to 12, and severe
= GCS of 8 or less). A minority of patients suffered from non-
severe TBI, with subsequent early deterioration leading to
ICU admission for care and monitoring. All patients in this
cohort had invasive ICP monitoring conducted in accordance
with the BTF guidelines [3].
Data collection
As part of recruitment to the multi-center high-resolution ICU
cohort of CENTER-TBI [8], all patients had demographics
prospectively recorded. Similarly, all patients had high-
frequency digital signals from ICU monitoring recorded
throughout their ICU stay, with the goal of initiating recording
within 24 h of injury. All digital ICU signals were further
processed (see the “Signal acquisition”/“Signal processing”
section). For the purpose of this study, the following admis-
sion demographic variables were collected: age, sex, admis-
sion Glasgow Coma Scale (GCS; total and motor), and admis-
sion pupillary response (bilaterally reactive, unilateral reac-
tive, bilateral unreactive). Only non-imputed raw data was
used for the purpose of this study, given the CENTER-TBI
study-wide imputation for missing data is still ongoing and
will be the focus of various other publications and studies.
Data was accessed on Sept 16, 2018, via Opal database soft-
ware [7].
Signal acquisition
Arterial blood pressure (ABP) was obtained through either
radial or femoral arterial lines connected to pressure transduc-
ers (Baxter Healthcare Corp. CardioVascular Group, Irvine,
CA). ICP was acquired via an intra-parenchymal strain gauge
probe (Codman ICP MicroSensor; Codman & Shurtleff Inc.,
Raynham, MA), parenchymal fiber optic pressure sensor
(Camino ICP Monitor, Integra Life Sciences, Plainsboro, NJ,
USA; https://www.integralife.com/) or external ventricular
drain. All signals were recorded using digital data transfer or
digitized via an A/D converter (DT9801; Data Translation,
Marlboro, MA), where appropriate, sampled at frequency of
100 Hz or higher, using the ICM+ software (Cambridge
Enterprise Ltd., Cambridge, UK, http://icmplus.neurosurg.
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cam.ac.uk) or Moberg CNS Monitor (Moberg Research Inc.,
Ambler, PA, USA) or a combination of both. Signal artifacts
were removed using both manual and automated methods
prior to further processing or analysis.
Signal processing
Post-acquisition processing of the above signals was conduct-
ed using ICM+. CPP was determined as CPP =MAP − ICP.
AMP was determined by calculating the fundamental Fourier
amplitude of the ICP pulse waveforms over a 10-s window,
updated every 10 s. Ten-second moving averages (updated
every 10 s to avoid data overlap) were calculated for all re-
corded signals: ICP, ABP (which produced MAP), AMP, and
CPP.
RAP, the continuous index of cerebral compensatory re-
serve was derived as the moving correlation coefficient be-
tween 30 consecutive 10-s mean windows of the parent sig-
nals (AMP and ICP), updated every minute. Finally,
compensatory-reserve-weighted ICP (wICP) was created for
each minute-by-minute observation via the following previ-
ously described method: wICP = (1 −RAP) × ICP.
Data were provided in minute-by-minute comma separated
variable sheets for the entire duration of recording for each
patient.
The basis for interpretation of wICP has been previously
published [2], and a brief summary is provided here: RAP
shows values around 0 when ICP is low and compensatory
reserve is good (linear part of pressure-volume curve). RAP
increases to +1 at higher ICP indicating poor compensatory
reserve (exponential part of pressure-volume curve). Such a
state is usually seen almost all the time after severe TBI.When
ICP increases to very high values, it provokes gradual collapse
of cerebral arterial bed and rapid decrease of cerebral blood
flow. RAP decreases towards zero or negative (deflection of
pressure-volume curve). This “very high value of ICP” lead-
ing to vascular collapse is individual and cannot be substituted
by any cohort-based average, like 20 or 25 mmHg.
Multiplying ICP by (1 −RAP) would magnify these values
of ICP when it interferes with integrity of cerebral blood flow,
by taking into account the cerebral compensatory reserve dur-
ing the calculation.
Data processing
Grand (i.e., the entire recording period) mean values of all
physiologic variables were calculated per patient. In addition,
post-ICM+ processing of RAP physiologic data occurred in R
(R Core Team (2016). R: A language and environment for
statistical computing. R Foundation for Statistical
Computing, Vienna, Austria. URL https://www.R-project.
org/), in keeping with our recent single-center retrospective
study on RAP in adult TBI, using the flux package. Area under
the curve for RAP (RAP AUC) was determined for each pa-
tient by integrating the RAP signal over time via a sequential
linear interpolation method within R using minute-by-minute
data. RAPAUC over time was calculated for RAP thresholds
of 0 and + 0.4. This is in keeping with previous work on the
association between RAP and admission brain imaging char-
acteristics [12]. The threshold for RAP was employed for the
purpose of summarizing RAP as a measure over the entire
recording period. Given RAP has a negative parabolic rela-
tionship with ICP, RAP values near 0 can mean both good and
poor compensatory reserve, depending on the situation. As
such, taking grand mean values of RAP over the entire record-
ing period can be done, but their interpretation is extremely
difficult, even during logistic regression analysis. This is why
we have focused on the area under the RAP vs. time relation-
ship, which provides a more objective and meaningful grand
summary measure when talking about a summary metric over
an entire recording period. This is not the case for wICP, as
each minute the wICP value is calculated from the ICP and
RAP value at that time, and is reflective of the physiologic
situation.
Statistics
All statistical analysis was conducted using R (R Core Team
(2016). R: A language and environment for statistical comput-
ing. R Foundation for Statistical Computing, Vienna, Austria.
URL https://www.R-project.org/) and XLSTAT (Addinsoft,
New York, NY; https://www.xlstat.com/en/) add-on package
to Microsoft Excel (Microsoft Office 15, Version 16.0.7369.
1323). Normality of continuous variables was assessed via the
Shapiro-Wilks test. For all testing described within, the alpha
was set at 0.05 for significance.
Despite GOSE being collected at both 6 and 12 months
post-injury in this cohort of patients, there was missing data
present in both categories of outcome. Thus, we combined
GOSE scores from both 6 and 12 months in order to provide
a “6- to 12-month” GOSE. For patients where GOSE was
reported for both 6 and 12 months, the superior GOSE score
was selected for analysis. Both ICP and wICP were assessed
across each ordinal category of GOSE using the Jonckheere-
Terpstra test with 1000 permutations, assessing for statistically
significant decreases in each ICP variable with increasing
GOSE grade.
GOSE was then dichotomized into the following catego-
ries: (A) alive (GOSE 2 to 8) vs. dead (GOSE 1) and (B)
favorable (GOSE 5 to 8) vs. unfavorable (GOSE 4 or less).
Demographics and physiologic variables were compared be-
tween each dichotomized group via t test, Mann-Whitney U,
and chi-square testing where appropriate. Box plots were cre-
ated for variables of interest comparing between dichotomized
groups.
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Univariate logistic regression (ULR) was conducted, com-
paring variables to both dichotomized outcomes, assessing
superiority using AUC and Delong’s test. Next, various
multi-variable models were created, which included ICP,
AMP, wICP, mean RAP, RAP AUC above 0 and RAP AUC
above + 0.4. This study represented the first validation of the
concept of wICP, and we therefore limited the complexity of
the analyses undertaken. We only used univariate logistic re-
gression, as we were primarily interested in validating previ-
ous single-center results in a multicenter dataset, to demon-
strate the feasibility of such an approach. No adjustment for
baseline characteristics was conducted, as study-wide imputa-
tion is currently being conducted to account for missing
values.
Results
Patient demographics
There were 196 patients from the CENTER-TBI high-resolu-
tion ICU cohort, with high-frequency physiologic signals and
complete demographic variables, which were included in this
study. The mean age was 46.6 ± 19.7 years, with 150 being
male. Median admission GCS was 8 (IQR 5 to 13), and mean
duration of physiologic monitoring was 159.3 ± 115.1 h. All
continuous variables were found to be non-parametrically dis-
tributed. Table 1 summarizes all of the patient demographics
and base physiologic information.
Physiology and outcome
Appendix A summarizes the comparison of various patient
demographics and physiology between the dichotomized
6- to 12-month outcome groups, using Mann-Whitney U
and chi-square test where appropriate. Both mean age and
mean wICP were noted to be significantly different be-
tween both alive/dead and favorable/unfavorable outcome
groups with high mean age (p < 0.0001 for alive/dead, and
p = 0.001 for favorable/unfavorable) and wICP (p < 0.0001
for alive/dead, and p = 0.002 for favorable/unfavorable)
associated with worse outcomes. Mean ICP was not signif-
icantly different between either dichotomized group (p =
0.134 for alive/dead, and p = 0.614 for favorable/
Table 1 Patient demographics,
physiology and outcome—entire
population
Mean/median (± sd or IQR)
Number of Patients 196
Age (years) 46.6 (19.7)
Sex Male 150
Female 46
Admission GCS (total) 8 (5 to 13)
Admission GCS (motor) 4 (2 to 6)
Admission pupil response Bilaterally reactive 128
Unilateral unreactive 17
Bilaterally unreactive 51
Duration of high-frequency
physiologic recording (hours)
159.3 (115.1)
ICP (mmHg) 14.3 (10.4)
AMP (mmHg) 2.6 (2.8)
CPP (mmHg) 69.6 (12.4)
wICP (mmHg) 5.8 (7.9)
RAP (a.u.) 0.614 (0.206)
RAPAUC—threshold of 0 5544.8 (4188.9)
RAPAUC—threshold of + 0.4 2625.8 (2158.6)
6- to 12-month GOSE 4 (2 to 6)
Number alive—6 to 12 months 149
Number dead—6 to 12 months 47
Number favorable outcome—6 to 12 months (GOSE 5 to 8) 94
Number unfavorable outcome—6 to 12 months (GOSE 1 to 4) 102
AMP pulse amplitude of ICP, a.u. arbitrary units, AUC integrated area under the RAP curve over time, CPP
cerebral perfusion pressure, GCS Glasgow Coma Scale, GOSE Glasgow Outcome Score—Extended, ICP intra-
cranial pressure, IQR inter-quartile range, RAP compensatory reserve index (moving correlation between AMP
and ICP), sd standard deviation, wICP compensatory-reserve-weighted ICP (wICP = (1 −RAP) × ICP)
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unfavorable). Figure 1 displays a box plot of ICP and wICP
across each category of GOSE at 6 to 12 months, with
wICP demonstrating a statistically significant decrease in
mean value with increasing GOSE category via
Jonckheere-Terpstra testing (p = 0.001). Mean ICP did
not display a significant decrease with increasing GOSE
score (p = 0.086). Figure 2 displays box plots of ICP and
wICP across both dichotomized outcome groups,
highlighting statistically significant lower mean wICP for
both the alive and favorable outcome groups.
Univariate logistic regression (ULR) analysis
Univariate logistic regression was performed for each de-
mographic and physiologic variable with both 6- to 12-
month dichotomized outcomes. Table 2 displays the re-
sults of the ULR analysis with AUCs and p values tabu-
lated for each variable. From this analysis, it was found
that age was statistically associated with both alive/dead
(AUC = 0.737; 95% CI 0.652–0.737; p < 0.0001) and
favorable/unfavorable (AUC = 0.680; 95% CI 0.605–
0.754; p < 0.0001) outcomes, in keeping with prior litera-
ture [3, 10]. Mean ICP was only significantly associated
with alive/dead (AUC = 0.642; 95% CI 0.538–0.746;
p < 0.0001), not favorable/unfavorable outcome (AUC =
0.495; 95% CI 0.413–0.577; p = 0.059). wICP displayed
a stronger association (i.e., larger AUC) with both alive/
dead and favorable/unfavorable outcomes (AUC = 0.712;
95% CI 0.615–0.810; p = 0.0002, and AUC = 0.626; 95%
CI 0.548–0.705; p = 0.015; respectively), compared to
ICP. This stronger relationship between wICP and out-
come held true even when comparing to models with
ICP and RAP AUC.
Comparing AUCs via Delong’s test indicated that there
was no difference between the AUCs for alive/dead out-
come association between ICP and wICP. However, wICP
demonstrated a statistically significant higher AUC com-
pared to ICP for favorable/unfavorable outcome (p =
0.002). Comparing the bivariate models with ICP and
RAP AUC to the univariate model with wICP, for both
alive/dead and favorable/unfavorable outcomes, the uni-
variate models with wICP alone displayed statistically
significant higher AUCs compared to the bivariate models
with ICP and RAP AUC (p < 0.05 for all; Delong’s test).
Figure 3 displays the receiver operating curves for ICP,
ICP + RAP AUC above 0.4, and wICP.
Fig. 1 a, b ICP and wICP across
GOSE categories. GOSE =
Glasgow Outcome Score—
Extended, ICP = intracranial
pressure, mmHg = millimeters of
Mercury, wICP = compensatory-
reserve-weighted ICP (wICP = (1
−RAP) × ICP). *p values
reported are for the Jonckheere-
Terpstra test, which was set to
assess for statistically significant
decreases in mean values of ICP
and wICP, with increase GOSE
category
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Finally, comparing the univariate models with wICP to
those containing (A) ICP + AMP and (B) ICP + AMP +
mean RAP, the univariate models with wICP displayed
statistically higher AUCs compared to both the ICP
+AMP and the ICP +AMP + mean RAP models for
favorable/unfavorable dichotomized outcomes (p < 0.05
for both; Delong’s test). However, there was no signifi-
cant difference between models for the alive/dead dichot-
omization, despite a trend to higher AUC values for the
univariate wICP model compared to both the ICP + AMP
and ICP + AMP +RAP models. Table 2 summarizes all
AUC, 95% confidence intervals, and p values for the
multi-variable models.
Discussion
Using data from a multicenter study, this manuscript confirms
the conceptual basis for wICP measurement and demonstrates
its ability to better discriminate mortality and functional out-
come when compared to conventional ICP measurement in
adult moderate/severe TBI. Two important aspects of our re-
sults deserve highlighting.
First, we have been able to confirm the association between
wICP and mortality displayed in the previous publication on
the topic using a multi-center data set. This provides
validating evidence that wICP may provide important infor-
mation, potentially beyond what ICP can provide, with lower
wICP values associated with reduced mortality. This was ex-
emplified in the stronger association between wICP and both
dichotomized 6- to 12-month outcomes. While these data pro-
vide important insights into cerebrovascular physiology, the
data do not, as yet, allow us to recommend adoption of wICP
as a clinically used measure at this time.
Second, we have been able to display the strong association
between wICP and favorable/unfavorable outcome, as dem-
onstrated using ULR and during the multi-variable models
tested. This is an important finding, as regardless of how
wICPwas compared to ICP, the statistical association between
wICP and favorable/unfavorable outcome was in favor of
wICP, with lower wICP values associated with favorable 6-
to 12-month outcome. However, as with the association be-
tween wICP and mortality, these results should be considered
preliminary and the use of wICP as a clinically monitored
variable cannot be justified at this time.
Limitations
Despite the promising results displayed, there are some im-
portant limitations to highlight. First, despite the data from the
CENTER-TBI high-resolution cohort being collected in a pro-
spective manner, the treatments and therapies received by the
Fig. 2 ICP and wICP across dichotomized 6 to 12 month outcomes.
GOSE = Glasgow Outcome Score—Extended, ICP = intracranial
pressure, mmHg = millimeters of mercury, wICP = compensatory-
reserve-weighted ICP (wICP = (1 −RAP) × ICP). a Mean ICP for alive
and dead outcomes. bMean ICP for favorable and unfavorable outcomes.
c Mean wICP for alive and dead outcomes. d Mean wICP for favorable
and unfavorable outcomes. Alive/dead dichotomization (alive = GOSE ≥
2, dead = GOSE 1). Favorable/unfavorable dichotomization (favorable =
GOSE 5 to 8, unfavorable = GOSE 1 to 4). *p values reported are for
Mann-Whitney U test, comparing mean values between dichotomized
groupings
1280 Acta Neurochir (2019) 161:1275–1284
patients for their TBI remains heterogeneous, with both
center-to-center and patient-by-patient variation. Such varia-
tion in treatment, complication profile, and hospital course
could potentially impact the physiologic signals recorded.
The potential impact of various ICU therapies on signal re-
sponse should be emphasized, as this data does not represent
the natural history of untreated cerebral physiology in
moderate/severe TBI. Thus, ICP-directed treatments, amongst
other therapies, may have impacted the physiology recorded.
Despite that, the results portrayed in this study parallel those
seen in the previous retrospective work on compensatory-
reserve-weighted ICP. Furthermore, there exists the potential
for within-patient variability of the physiologic signals over
time, either in response to individual therapeutic measures, or
based on individual physiologic differences between patients.
This within-patient variability may have impacted the results
seen within the preliminary results presented in this manu-
script. As such, they require much further investigation and
validation. Future analysis of wICP and RAP will need to
account for this and may benefit from more complex time-
series techniques, mixed effects, and latent class modelling.
Second, the overall patient numbers with outcome and
basic demographics were low at 196. This high-resolution
cohort was a small specialty sub-cohort within the larger
CENTER-TBI data collection scheme. While extrapola-
tion to other (or wider) populations of TBI patients re-
mains unproven, we believe that the strength of statisti-
cally significant results displayed in this study is impor-
tant, and warrant further exploration in larger multi-center
TBI studies, where such high-frequency physiologic data
is collected.
Third, we specifically did not adjust for baseline ad-
mission characteristics through multi-variable logistic re-
gression analysis, given the CENTER-TBI study-wide im-
putation and validation processes for missing data is still
ongoing and will be the focus of various other publica-
tions and studies, once completed. As such, we can only
comment on univariate association with outcome at this
time, as the focus was to provide a multi-center validation
study for the previous retrospective single-center results
from Cambridge. It is possible that through adjusting for
baseline admission characteristics, the results may not be
as significant. Such multi-variable models will be the fo-
cus of future studies from both CENTER-TBI and other
high-resolution data sets.
Fourth, despite strong associations with global outcome at
6 to 12 months, and results indicating the wICP may be supe-
rior to ICP in outcome association, there are currently no
Table 2 Univariate/bivariate
logistic regression analysis for
IMPACT core and physiologic
variables
Variable A/D AUC (95% CI) p value F/U AUC (95% CI) p value
Age 0.737 (0.652–0.737) < 0.0001 0.680 (0.605–0.754) < 0.0001
Admission GCS Motor 0.559 (0.409–0.612) 0.160 0.576 (0.497–0.655) 0.022
Admission Pupil Reactivity 0.440 (0.336–0.524) 0.196 0.440 (0.372–0.507) 0.228
Mean ICP 0.642 (0.538–0.746) < 0.0001 0.495 (0.413–0.577) 0.059
Mean AMP 0.671 (0.567–0.775) < 0.0001 0.527 (0.445–0.609) 0.045
Mean RAP* 0.669 (0.575–0.762) 0.002 0.659 (0.582–0.735) 0.0007
Mean RAPAUC Above 0 0.619 (0.526–0.712) 0.015 0.495 (0.413–0.576) 0.359
Mean RAPAUC above + 0.4 0.635 (0.544–0.727) 0.007 0.539 (0.458–0.620) 0.137
wICP 0.712 (0.615–0.810) 0.0002 0.627 (0.548–0.705) 0.015
Multi-variable models
ICP +RAPAUC Above 0 0.618 (0.525–0.711) < 0.0001 0.495 (0.414–0.577) 0.126
ICP +RAPAUC above + 0.4 0.633 (0.541–0.724) < 0.0001 0.538 (0.457–0.619) 0.069
ICP +AMP 0.657 (0.553–0.760) 0.007 0.508 (0.426–0.590) 0.222
ICP +AMP +mean RAP 0.653 (0.548–0.758) 0.0001 0.503 (0.421–0.586) 0.001
Italicized p values are those reaching significance (i.e., p < 0.05). *Despite these mean values of RAP dem-
onstrate significant associations with the dichotomized outcomes, they are difficult to interpret given the nature
of RAP. RAP values near 0 can mean both good and poor compensatory reserve, as such, during the averaging
process to produce mean values over a recording period, it becomes difficult to interpret the meaning of such
measures
AMP pulse amplitude of ICP, A/D alive/dead, AUC area under the receiver operating curve, CI confidence
interval, F/U favorable/unfavorable outcome (i.e., favorable = Glasgow Outcome Scale of 5 to 8; unfavorable
= GlasgowOutcome Scale of 1 to 4), ICP intra-cranial pressure, IMPACT International Mission for Prognosis and
Analysis of Clinical Trials, RAP compensatory reserve index (moving correlation between AMP and ICP), RAP
AUC integrated area under the RAP curve over time, wICP compensatory-reserve-weighted ICP (wICP = (1 −
RAP) × ICP)
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treatment thresholds for wICP in TBI. This lack of treatment
thresholds for wICP is in contrast to existing BTF suggested
treatment thresholds for ICP. Such analysis of wICP thresh-
olds will need to occur with larger, perhaps combined, pro-
spective and retrospective high-frequency physiologic data
sets in TBI patients.
Finally, wICP should still be considered an experimen-
tal variable despite the significant results in this study. To
date, with this current study, only three works have eval-
uated compensatory-reserve-weighted ICP, all providing
complementary results [2, 6]. Currently, wICP should
not replace ICP in monitoring and care of moderate and
severe TBI patients. Much further multi-center work is
required to validate this measure as a clinically valuable
physiologic parameter in TBI.
Conclusions
Compensatory-reserve-weighted ICP displays superior out-
come association over ICP for both alive/dead and
favorable/unfavorable dichotomized outcomes at 6 to
12 months in adult TBI, through univariate analysis. Lower
wICP is associated with better global outcomes. The results of
this study provide multi-center validation of those seen in
Fig. 3 Univariate logistic regression—ICP, ICP + RAP AUC above +
0.4, and wICP receiver operating curves. GOSE = Glasgow Outcome
Scale Extended, ICP = intracranial pressure, ULR = univariate logistic
regression, wICP = compensatory-reserve-weighted ICP (wICP = (1 −
RAP) × ICP). a ICP ULR for alive/dead outcome. b ICP ULR for
favorable/unfavorable outcome. c ICP + RAP AUC above + 0.4 ULR
for alive/dead outcome. d ICP + RAP AUC above + 0.4 for favorable/
unfavorable outcome. ewICP ULR for alive/dead outcome. fwICP ULR
for favorable/unfavorable outcome. Alive/dead dichotomization (alive =
GOSE ≥ 2, dead = GOSE 1). Favorable/unfavorable dichotomization
(favorable = GOSE 5 to 8, unfavorable = GOSE 1 to 4). *Indicates
AUC reported failed to reach statistical significance in the ULR model
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previous single-center studies. Further work is required to
identify treatment thresholds for wICP in adult TBI.
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